Author

C. Mazurek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 3 Assay:bulk RNA-seq· 1 Organism:virus· 1

Frequent Co-Authors

A.-r. Collier· 4 shared J. Miller· 4 shared N. Hachmann· 4 shared B. Korber· 3 shared D. H. Barouch· 3 shared M. Rowe· 3 shared N. Lasrado· 3 shared N. Surve· 3 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A.-r. Collier

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.2.86

N. Lasrado, A.-r. Collier, N. Hachmann, J. Miller, M. Rowe, E. Schonberg, S. Rodrigues, A. LaPiana, R. Patio, T. Anand, J. Fisher, C. Mazurek, R. Guan, K. Wagh, J. Theiler, , D. H. Barouch

This study evaluates the neutralization escape of the SARS-CoV-2 Omicron subvariant BA.2.86 compared to other variants, finding lower neutralization by antibodies than BA.2 but comparable to circulating variants.

bioRxiv · Sep 4, 2023Microbiology

Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters

N. Lasrado, A.-r. Collier, J. Miller, N. Hachmann, J. Liu, M. Sciacca, C. Wu, T. Anand, E. Bondzie, J. Fisher, C. Mazurek, R. Patio, O. Powers, S. Rodrigues, M. Rowe, , D. H. Barouch

This study evaluates the durability of humoral and cellular immune responses to XBB.1.5 after bivalent mRNA boosters, finding waning neutralizing antibody titers but preserved T cell responses.

bioRxiv · Jan 22, 2023 · PreprintImmunology

Substantial Neutralization Escape by the SARS-CoV-2 Omicron Variant BQ.1.1

J. Miller, N. Hachmann, A.-r. Collier, N. Lasrado, C. Mazurek, R. Patio, O. Powers, N. Surve, J. Theiler, B. Korber, D. H. Barouch

The paper shows BQ.1.1 SARS-CoV-2 variant has greater neutralization escape compared to BA.5, with lower NAb titers in vaccinated individuals.

bioRxiv · Nov 1, 2022 · PreprintImmunology

Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters

A.-r. Collier, J. Miller, N. Hachmann, K. McMahan, J. Liu, E. Bondzie, L. Gallup, M. Rowe, E. Shonberg, S. Thai, J. Barrett, E. Borducchi, E. Bouffard, C. Jacob-Dolan, C. Mazurek, , D. Barouch

This study compares neutralizing antibody titers after monovalent and bivalent mRNA boosters against SARS-CoV-2, finding comparable levels against BA.5.

bioRxiv · Oct 24, 2022Immunology